A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With Psoriasis

Summary

This study will examine the safety and efficacy in subjects with moderate to severe psoriasis, as measured by Psoriasis Area and Severity Index(PASI), Body Surface Area (BSA), Dermatology Life Quality Index (DLQI) and other assessments.

Timeline

Start

2012-11

Primary completion

2014-11

Completion

2014-11

Drugs

Indications